MALDI-TOF MS as evolving cancer diagnostic tool: a review

Area of Science:

• Clinical proteomics
• Analytical chemistry
• Biomarker discovery

Background:

• Mass spectrometry advancements are crucial for disease diagnosis.
• Clinical proteomics offers reliable methods for biomarker discovery and monitoring.
• Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) is a key technology in this field.

Purpose of the Study:

• To review MALDI-TOF profiling techniques for cancer biomarker detection.
• To highlight recent advances in MALDI-TOF applications for cancer diagnostics.
• To explore the potential of MALDI-TOF in revolutionizing cancer diagnosis.

Main Methods:

• Analysis of healthy and cancerous tissues using MALDI-TOF mass spectrometry imaging.
• Identification of cancer-specific proteomic changes.
• Review of MALDI-TOF profiling techniques and recent literature (2011-2013).

Main Results:

• MALDI-TOF enables efficient biomarker discovery and monitoring in clinical proteomics.
• MALDI-TOF imaging can identify cancer-specific proteomic signatures in tissues.
• The technique has potential for revolutionizing cancer diagnostics through biomarker quantification and tissue imaging.

Conclusions:

• MALDI-TOF mass spectrometry is a powerful tool for cancer biomarker discovery and diagnostics.
• MALDI-TOF profiling techniques are valuable for detecting cancer biomarkers across various cancer types.
• Continued advancements in MALDI-TOF hold significant promise for improving clinical cancer diagnosis and monitoring.